Condition: Chronic Migraine · Sponsor: University of Calgary
This study will evaluate the efficacy and safety of cannabis for the treatment of chronic migraine headaches. Study subjects will be randomized to one of three groups: lower dose CBD, higher dose CBD or placebo.
This description comes directly from the study's public registry record.
CHAMP Research (Calgary Headache Assessment & Management Prog) · 403-956-3427 or 403-956-3548 · champ.research@ucalgary.ca
Always discuss trial participation with your own doctor first.
| CHAMP Research (Calgary Headache Assessment & Management Program) | Calgary, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03972124